{"id":"https://openalex.org/W4210275428","doi":"https://doi.org/10.1007/s40273-021-01121-7","title":"Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review","display_name":"Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review","publication_year":2022,"publication_date":"2022-02-02","ids":{"openalex":"https://openalex.org/W4210275428","doi":"https://doi.org/10.1007/s40273-021-01121-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/35112331","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9095534"},"language":"en","primary_location":{"id":"doi:10.1007/s40273-021-01121-7","doi":"https://doi.org/10.1007/s40273-021-01121-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40273-021-01121-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40273-021-01121-7.pdf","source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40273-021-01121-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079060977","display_name":"Min Huang","orcid":"https://orcid.org/0000-0003-1960-4552","observed_orcids":["https://orcid.org/0000-0003-1960-4552"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Min Huang","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA. Min_Huang@merck.com","Merck & Co., Inc., Kenilworth, NJ, USA"],"raw_orcid":"https://orcid.org/0000-0003-1960-4552","affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA. Min_Huang@merck.com","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076055015","display_name":"Amin Haiderali","orcid":"https://orcid.org/0000-0002-6858-1564","observed_orcids":["https://orcid.org/0000-0002-6858-1564"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amin Haiderali","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052972843","display_name":"Grace E. Fox","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grace E. Fox","raw_affiliation_strings":["PRECISIONheor, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PRECISIONheor, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061816287","display_name":"Andrew M. Frederickson","orcid":"https://orcid.org/0000-0003-1970-9805","observed_orcids":["https://orcid.org/0000-0003-1970-9805"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Frederickson","raw_affiliation_strings":["PRECISIONheor, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PRECISIONheor, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cortes","raw_affiliation_strings":["International Breast Cancer Center (IBCC), Barcelona, Spain","Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Breast Cancer Center (IBCC), Barcelona, Spain","institution_ids":[]},{"raw_affiliation_string":"Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017728105","display_name":"Peter Andreas Fasching","orcid":"https://orcid.org/0000-0003-4885-8471","observed_orcids":["https://orcid.org/0000-0003-4885-8471","https://orcid.org/0000-0003-1709-1079"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I4210149747","display_name":"Comprehensive Cancer Center Erlangen","ror":"https://ror.org/05jfz9645","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210149747"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter A. Fasching","raw_affiliation_strings":["Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen, EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen, Nuremberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen, EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen, Nuremberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053","https://openalex.org/I4210149747"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joyce O\u2019Shaughnessy","raw_affiliation_strings":["Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA","institution_ids":["https://openalex.org/I2802366037"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5079060977"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":4290,"currency":"USD","value_usd":4290},"apc_paid":{"value":4290,"currency":"USD","value_usd":4290},"fwci":1.5759,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.84588644,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"40","issue":"5","first_page":"519","last_page":"558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/economic-burden","display_name":"economic burden","score":0.9869999885559082},{"id":"https://openalex.org/keywords/humanistic-burden","display_name":"humanistic burden","score":0.984000027179718},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8569999933242798},{"id":"https://openalex.org/keywords/productivity-loss","display_name":"productivity loss","score":0.8429999947547913},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9380000233650208},{"id":"https://openalex.org/keywords/recurrence","display_name":"recurrence","score":0.6069999933242798},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8980000019073486},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.5099999904632568},{"id":"https://openalex.org/keywords/indirect-costs","display_name":"indirect costs","score":0.5249999761581421},{"id":"https://openalex.org/keywords/eortc-qlq-c30","display_name":"EORTC QLQ-C30","score":0.7770000100135803},{"id":"https://openalex.org/keywords/fact-b","display_name":"FACT-B","score":0.7680000066757202},{"id":"https://openalex.org/keywords/eortc-qlq-br23","display_name":"EORTC QLQ-BR23","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tumor-stage","display_name":"tumor stage","score":0.3580000102519989},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.5809999704360962},{"id":"https://openalex.org/keywords/health-utility","display_name":"health utility","score":0.4779999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7484084963798523},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6063006520271301},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.6044734716415405},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.5477437973022461},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.5462167263031006},{"id":"https://openalex.org/C2778980733","wikidata":"https://www.wikidata.org/wiki/Q5333315","display_name":"EconLit","level":3,"score":0.5117692947387695},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.463521808385849},{"id":"https://openalex.org/C524218345","wikidata":"https://www.wikidata.org/wiki/Q31218","display_name":"Health economics","level":3,"score":0.4283205270767212},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.42755988240242004},{"id":"https://openalex.org/C137992405","wikidata":"https://www.wikidata.org/wiki/Q1137608","display_name":"Health administration","level":3,"score":0.4121495485305786},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3698212504386902},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.35169845819473267},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.31881290674209595},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23483529686927795},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.23412936925888062},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.13278314471244812},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s40273-021-01121-7","doi":"https://doi.org/10.1007/s40273-021-01121-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40273-021-01121-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40273-021-01121-7.pdf","source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9095534","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9095534","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoeconomics","raw_type":"Text"},{"id":"pmid:35112331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35112331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:spr:pharme:v:40:y:2022:i:5:d:10.1007_s40273-021-01121-7","doi":null,"is_oa":false,"landing_page_url":"http://link.springer.com/10.1007/s40273-021-01121-7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s40273-021-01121-7","doi":"https://doi.org/10.1007/s40273-021-01121-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40273-021-01121-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40273-021-01121-7.pdf","source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320314481","display_name":"Ipsen Biopharmaceuticals","ror":"https://ror.org/03bzkqg41"},{"id":"https://openalex.org/F4320315087","display_name":"Clovis Oncology","ror":"https://ror.org/04ps4d441"},{"id":"https://openalex.org/F4320315641","display_name":"Halozyme","ror":"https://ror.org/001x5ea44"},{"id":"https://openalex.org/F4320317943","display_name":"Heron Therapeutics","ror":"https://ror.org/05jnq7w45"},{"id":"https://openalex.org/F4320317987","display_name":"Syndax Pharmaceuticals","ror":"https://ror.org/02w9kv048"},{"id":"https://openalex.org/F4320318955","display_name":"Puma Biotechnology","ror":"https://ror.org/053kr4v45"},{"id":"https://openalex.org/F4320319266","display_name":"G1 Therapeutics","ror":"https://ror.org/048389405"},{"id":"https://openalex.org/F4320319515","display_name":"Seagen","ror":null},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320328455","display_name":"Ipsen","ror":"https://ror.org/00d801g55"},{"id":"https://openalex.org/F4320331694","display_name":"Aptitude Health","ror":"https://ror.org/03cxemy98"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332195","display_name":"Samsung","ror":"https://ror.org/04w3jy968"},{"id":"https://openalex.org/F4320333648","display_name":"Pharmacyclics","ror":"https://ror.org/03hm8w204"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4210275428.pdf","grobid_xml":"https://content.openalex.org/works/W4210275428.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W1577562053","https://openalex.org/W1848007259","https://openalex.org/W1857624176","https://openalex.org/W1966727713","https://openalex.org/W1967997862","https://openalex.org/W1974287672","https://openalex.org/W2010700151","https://openalex.org/W2031428574","https://openalex.org/W2038702727","https://openalex.org/W2043071080","https://openalex.org/W2077880074","https://openalex.org/W2092610057","https://openalex.org/W2096027508","https://openalex.org/W2098923148","https://openalex.org/W2101814490","https://openalex.org/W2113411375","https://openalex.org/W2115396038","https://openalex.org/W2128458647","https://openalex.org/W2137971505","https://openalex.org/W2140811091","https://openalex.org/W2155426660","https://openalex.org/W2156098321","https://openalex.org/W2167571044","https://openalex.org/W2235647135","https://openalex.org/W2344782456","https://openalex.org/W2542344455","https://openalex.org/W2560635244","https://openalex.org/W2588681363","https://openalex.org/W2593907417","https://openalex.org/W2594469314","https://openalex.org/W2597892796","https://openalex.org/W2781695502","https://openalex.org/W2803099840","https://openalex.org/W2887648164","https://openalex.org/W2887849312","https://openalex.org/W2898594723","https://openalex.org/W2911699492","https://openalex.org/W2912093749","https://openalex.org/W2912993657","https://openalex.org/W2925759711","https://openalex.org/W2950197636","https://openalex.org/W2954596109","https://openalex.org/W2991792334","https://openalex.org/W2995873565","https://openalex.org/W2996025299","https://openalex.org/W3006693642","https://openalex.org/W3013474018","https://openalex.org/W3013953839","https://openalex.org/W3025779808","https://openalex.org/W3026276469","https://openalex.org/W3026706622","https://openalex.org/W3027327310","https://openalex.org/W3027439079","https://openalex.org/W3041878547","https://openalex.org/W3082718392","https://openalex.org/W3086222759","https://openalex.org/W3092313706","https://openalex.org/W3103504671","https://openalex.org/W3108087185","https://openalex.org/W3110314935","https://openalex.org/W3128646645","https://openalex.org/W3137861363","https://openalex.org/W3139201939","https://openalex.org/W3169608352","https://openalex.org/W3172815138","https://openalex.org/W4206666777","https://openalex.org/W4211123279"],"related_works":["https://openalex.org/W4389205040","https://openalex.org/W2954596109","https://openalex.org/W2995873565","https://openalex.org/W4407363511","https://openalex.org/W4405748239","https://openalex.org/W2560507770","https://openalex.org/W6920992571","https://openalex.org/W4200399165","https://openalex.org/W1974287672","https://openalex.org/W2035760775"],"abstract_inverted_index":{"BACKGROUND:":[0],"Triple-negative":[1],"breast":[2,10],"cancer":[3,214,228],"(TNBC)":[4],"accounts":[5],"for":[6,58,342,362],"10-20%":[7],"of":[8,36,46,52,82,89,122,135,158,174,218,224,235,241,277,284,308,356,371],"all":[9],"cancers":[11],"(BCs).":[12],"It":[13],"is":[14,324],"more":[15],"commonly":[16],"diagnosed":[17],"in":[18,106,163,188,197,293,305],"younger":[19],"women":[20],"and":[21,49,62,85,151,169,192,203,212,274,320,334,336,340,353,358],"often":[22],"has":[23],"a":[24,42,101,232,327],"less":[25],"favorable":[26],"prognosis":[27],"compared":[28,311],"with":[29,208,221,288,297,312,326],"other":[30,129],"BC":[31],"subtypes.":[32],"OBJECTIVE:":[33],"The":[34,120,142,172,239],"objective":[35],"this":[37],"study":[38,164,345],"was":[39,69,104,139,291],"to":[40,54,95,127,185,195,245,251,263,270,366],"provide":[41],"literature-based":[43],"extensive":[44],"overview":[45],"the":[47,78,86,107,136,148,155,222,279,347,351,360,367],"economic":[48,149,329,352],"humanistic":[50,156,354],"burden":[51,150,157,330,355],"TNBC":[53,191,294,323,357,372],"assist":[55],"medical":[56,179],"decisions":[57],"healthcare":[59,332],"payers,":[60],"providers,":[61],"patients.":[63,295,343],"METHODS:":[64],"A":[65,281],"systematic":[66],"literature":[67,349],"review":[68,143],"performed":[70,105],"using":[71],"multiple":[72],"databases,":[73],"including":[74],"EMBASE,":[75],"MEDLINE,":[76],"Econlit,":[77],"Cochrane":[79,87],"Central":[80],"Register":[81],"Controlled":[83],"Trials,":[84],"Database":[88],"Systematic":[90],"Reviews,":[91],"from":[92,115,182,193,249],"database":[93,114],"inception":[94],"16":[96],"May":[97],"2021.":[98,119],"In":[99],"addition,":[100],"targeted":[102],"search":[103],"Northern":[108],"Light":[109],"Life":[110],"Sciences":[111],"Conference":[112],"Abstracts":[113],"2016":[116],"through":[117],"June":[118],"bibliographies":[121],"included":[123,137],"articles":[124],"were":[125,261],"reviewed":[126],"identify":[128],"potentially":[130],"relevant":[131],"publications.":[132],"Quality":[133],"assessment":[134],"studies":[138,146,153],"conducted.":[140],"RESULTS:":[141],"identified":[144],"19":[145],"assessing":[147,154],"10":[152],"TNBC.":[159,200],"Studies":[160],"varied":[161],"widely":[162],"design,":[165],"settings,":[166],"patient":[167,254],"populations,":[168],"time":[170],"horizons.":[171],"estimates":[173,240],"mean":[175],"per-patient":[176],"annual":[177],"direct":[178,237],"costs":[180,202,223,230,243,258],"ranged":[181,248],"around":[183],"$20,000":[184],"over":[186],"$100,000":[187,194],"stage":[189,198,215],"I-III":[190],"$300,000":[196],"IV":[199],"Healthcare":[201],"resource":[204],"utilization":[205],"increased":[206,213],"significantly":[207,271,302],"disease":[209,289],"recurrence,":[210],"progression,":[211],"or":[216,299],"line":[217],"therapy.":[219],"Compared":[220],"systemic":[225],"anticancer":[226],"therapy,":[227],"management":[229],"comprised":[231],"larger":[233],"portion":[234],"total":[236],"costs.":[238],"indirect":[242],"due":[244,365],"productivity":[246,273,339],"loss":[247],"$207":[250],"$1573":[252],"per":[253,255],"month":[256],"(all":[257],"presented":[259],"above":[260],"adjusted":[262],"2021":[264],"US":[265],"dollars).":[266],"Cancer":[267],"recurrence":[268],"led":[269],"reduced":[272,338],"greater":[275,303],"rates":[276],"leaving":[278],"workforce.":[280],"rapid":[282],"deterioration":[283],"health":[285],"utility":[286],"associated":[287,325],"progression":[290],"observed":[292],"Treatment":[296],"pembrolizumab":[298],"talazoparib":[300],"showed":[301],"improvements":[304],"health-related":[306],"quality":[307],"life":[309],"(HRQoL)":[310],"chemotherapy,":[313],"as":[314],"measured":[315],"by":[316],"EORTC":[317],"QLQ-C30,":[318],"QLQ-BR23,":[319],"FACT-B.":[321],"CONCLUSION:":[322],"substantial":[328],"on":[331,350],"systems":[333],"societies":[335],"considerably":[337],"HRQoL":[341],"This":[344],"synthesized":[346],"published":[348],"highlighted":[359],"need":[361],"continued":[363],"research":[364],"rapidly":[368],"changing":[369],"landscape":[370],"care.":[373]},"counts_by_year":[{"year":2026,"cited_by_count":13},{"year":2025,"cited_by_count":21},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-02-08T00:00:00"}